Antimicrobial-resistant infections are a leading cause of global death, killing nearly 1.3 million people yearly and outpacing malaria and HIV, according to a 2022 study published in The Lancet. In January, a study published in Frontiers in Microbiology confirmed mounting evidence that adding silver nanoparticles to certain antibiotics boosts their ability to kill resistant bacteria.
Knowledge of silver’s antimicrobial value has been around since ancient times. However, silver nanoparticles (AgNP), with their tiny spheres interacting at the cellular level, signify a new frontier in fighting bacteria, gaining more attention over the past two decades.
